RxDoctor Payments Data

Heather Todd

Family · Quincy, ILNPI 1831540459

Payments from drug & device makers

$367in general payments, 2019–2025

Across 19 payments — averaging $19.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$80
  • Otsuka America Pharmaceutical, Inc.$53
  • Scpharmaceuticals Inc.$45
  • Novo Nordisk$44
  • AstraZeneca$30
  • Ardelyx, Inc.$29
  • plus $86 from 4 others

What the payments were for

  • Food & beverage$34393%
  • Other$247%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$367 in reported general payments places this provider in the 55th percentile of 4,941 family providers in Illinois.

See all family providers in Illinois

Medicare billing

Part B allowed, 2024
$187,868
Medicare patients
820
Services billed
2,188

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban65$36,961
FarxigaDapagliflozin Propanediol57$34,828
XareltoRivaroxaban37$28,381
JanuviaSitagliptin Phosphate18$22,652
JardianceEmpagliflozin22$20,858
MyrbetriqMirabegron16$13,188
Combivent RespimatIpratropium/Albuterol Sulfate16$8,012
TradjentaLinagliptin13$7,555
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog23$7,014
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen197$5,553
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr12$4,677
Sucralfate26$4,577
Pregabalin53$4,283
Potassium Chloride129$4,107
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen42$3,078

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga$30$34,82857 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 4,941 family providers in Illinois.

Other family in Quincy

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →